Sign in

CIK 0001885522

  • Non-accelerated filer
  • Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
844367680
Phone
+1 857-760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 20,100 shares (grant or award)
  2. 4 Grant or award Director acquired 20,100 shares (grant or award)
  3. 4 Grant or award Director acquired 20,100 shares (grant or award)
  4. 4 Grant or award Director acquired 20,100 shares (grant or award)
  5. 4 Grant or award Director acquired 20,100 shares (grant or award)
  6. 4 Gift Chief Strategy Officer gave 114,703 shares (gift)
  7. 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
  8. 4 Grant or award Chief Strategy Officer acquired 97,500 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 85,000 shares (grant or award)
  10. 4 Grant or award Director acquired 171,250 shares (grant or award)
  11. 4 Grant or award President & CEO acquired 80,000 shares (grant or award)
  12. 4 Grant or award Milligan Michael Lee acquired 20,625 shares (grant or award)
  13. 4 Grant or award Head of R&D acquired 50,000 shares (grant or award)
  14. 4 Other acquisition 10% owner acquired 1,879,654 shares (other)
  15. 4 Other acquisition 10% owner acquired 1,879,654 shares (other)
  16. 4 Other acquisition Director acquired 1,893,651 shares (other)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy Director bought 35,010 shares at an average $11.77 ($412,140)
  20. 4 Open-market buy 10% owner bought 35,010 shares at an average $11.77 ($412,140)

Page 4 of 6 · 118 filings